Officials at Health NZ and Pharmac are scrambling to resolve a shortage of supplies of long-acting olanzapine injections prescribed to people with schizophrenia. Alex Spence reports that psychiatrists are concerned some of their patients could experience a relapse of psychotic symptoms.
New Zealand 